News & Updates

Show Multimedia Only

Rice, refined carbohydrates raise risk of liver disease

08 Aug 2026

Higher intakes of total refined carbohydrate and rice appear to increase the risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), but consumption of wheat, coarse grains, and yams may mitigate such threat, suggests a study.

Rice, refined carbohydrates raise risk of liver disease

08 Aug 2026

Simvastatin extends survival in patients with cirrhosis after variceal bleed

07 Aug 2026

Treatment with simvastatin appears to improve survival in some patients with cirrhosis after variceal bleed, suggests a study. The drug also reduces the incidence of new-onset, refractory ascites and its complications.

Simvastatin extends survival in patients with cirrhosis after variceal bleed

07 Aug 2026

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

Low levels of free testosterone (FT) appear to contribute to frailty in male patients with advanced chronic liver disease (CLD), according to a study.

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

Carvedilol outdoes nadolol, propranolol in preventing decompensation events in cirrhosis

24 Jul 2026

Treatment with carvedilol, compared with nadolol or propranolol, results in reduced rates of major decompensation events among patients with cirrhosis, a study has shown.

Carvedilol outdoes nadolol, propranolol in preventing decompensation events in cirrhosis

24 Jul 2026

Patients with liver cirrhosis may sleep better with lemborexant

23 Jul 2026 by

Treatment with lemborexant helps manage sleep disturbances in patients with liver cirrhosis, as shown in the crossover RESTORE trial.

Patients with liver cirrhosis may sleep better with lemborexant

23 Jul 2026

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

22 Jul 2026 by

Treatment with the thyroid hormone beta agonist resmetirom significantly improves qFibrosis continuous values (qFC), categorical stages (qFS), and individual collagen features associated with fibrosis progression at week 52 compared with placebo in patients with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), as shown in the phase III MAESTRO-NASH trial.

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

22 Jul 2026

Coffee may protect against liver disease, including cancer

21 Jul 2026 by

A recent study has shown an association between higher coffee intake and lower risks of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality.

Coffee may protect against liver disease, including cancer

21 Jul 2026

Statins may protect against site-specific cancers

20 Jul 2026

Statin use may reduce the risk of cancer at several sites, including the liver, lung, colon, and rectum, especially for individuals with diabetes, as shown in a retrospective study.

Statins may protect against site-specific cancers

20 Jul 2026

Coffee drinking may promote liver health

18 Jul 2026

High coffee intake may have protective effects on the liver, with reduced risk of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, as reported in a study.

Coffee drinking may promote liver health

18 Jul 2026

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

16 Jul 2026 by

In individuals receiving odevixibat for progressive familial intrahepatic cholestasis 2 (PFIC2), also known as bile salt export pump (BSEP) deficiency, reductions in serum bile acid (sBA) levels correlated with improvements in key liver function tests (LFTs), according to a post hoc subgroup analysis presented at ESPGHAN 2026.

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

16 Jul 2026

News & Updates

Showing Hepatology articles

Showing

Specialty:

Rice, refined carbohydrates raise risk of liver disease

Rice, refined carbohydrates raise risk of liver disease

Simvastatin extends survival in patients with cirrhosis after variceal bleed

Simvastatin extends survival in patients with cirrhosis after variceal bleed

Low FT levels linked to frailty in men with advanced CLD

Low FT levels linked to frailty in men with advanced CLD

Carvedilol outdoes nadolol, propranolol in preventing decompensation events in cirrhosis

Carvedilol outdoes nadolol, propranolol in preventing decompensation events in cirrhosis

Patients with liver cirrhosis may sleep better with lemborexant

Patients with liver cirrhosis may sleep better with lemborexant

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

Resmetirom shows antifibrotic efficacy in MASH via AI-based quantification

Coffee may protect against liver disease, including cancer

Coffee may protect against liver disease, including cancer

Statins may protect against site-specific cancers

Statins may protect against site-specific cancers

Coffee drinking may promote liver health

Coffee drinking may promote liver health

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2